<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20201121049454N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-10-21</date_registration>
      <primary_sponsor>Shahid Beheshti University of Medical Sciences</primary_sponsor>
      <public_title>Comparison of cervical specimen margins obtained from LEEP surgery with and without colposcop</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of cervical specimen margins obtained from LEEP surgery with and without colposcop</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-10-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>140</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/52716</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: To equalize the two groups, we use the block randomization method. First, we consider the capacity of the block 4 and determine all permutations (6 blocks). All possible blocks are arranged as follows: Block 1: ABAB, Block 2: AABB, Block 3: ABBA, Block 4: BBAA, Block 5: BAAB and Block 6: BABA. We called these blocks randomly from numbers 1 to 6. Choose a random number between 1 and 6. For example, the number 4 was chosen randomly, so the first person receives treatment "B", the second person receives treatment "B", the third person receives treatment "A" and the fourth person receives treatment "A", which indicates the block 4 is the first block for patients entering the study. Then we select the second block at random. This process is repeated until we reach the desired sample, Blinding description: The participants are assigned to study A and B codes and until the end of the study, these codes are not decoding for patients. That is, participating people, until the end of the study, are not informed that LEEP surgery with colposcopy is for group A or B groups.</study_design>
      <phase>N/A</phase>
      <hc_freetext>cervical cancer.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: All patients referred to the clinic of Mahdieh and Imam Hossein hospitals who are LEEP candidates for any reason are divided into two groups after obtaining consent. In one group, a colposcope is used during the LEEP and the cervix is ​​viewed under armed vision. The LEEP operation is performed and the patients are entered into each group based on a random table. The LEEP operation is performed by two gynecological oncology fellowships. Examined by an experienced pathologist. Intervention 2: Control group: Patients referred to the clinic of Mahdieh and Imam Hossein hospitals who are candidates for LEEP for any reason are divided into two groups after obtaining consent. In the control group during LEEP without colposcope and only after applying acetic acid on the cervix and view with the naked eye LEEP operation is performed by two gynecological oncology fellowships. Examined by an experienced pathologist.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Information on the main outcome

When:
After printing the results

To whom:
Researchers working in academic and scientific institutions

Conditions:
Provided that the complete details of the data are entered.

Where to obtain:
a.moridi@sbmu.ac.ir

How to obtain:
Send request via email

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Atefeh Moridi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Tehran .Shousha Fadaiyan Islam St. Shishe Garkhaneh St. Boroujerdi St. Mahdieh Hospital</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۱۱۸۵۸۱۷۳۱۱</zip>
        <telephone>+98 21 5506 2628</telephone>
        <email>a.moridi@sbmu.ac.ir</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Atefeh Moridi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Tehran .Shousha Fadaiyan Islam St. Shishe Garkhaneh St. Boroujerdi St. Mahdieh Hospital</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۱۱۸۵۸۱۷۳۱۱</zip>
        <telephone>+98 21 5506 2628</telephone>
        <email>a.moridi@sbmu.ac.ir</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>All patients between the ages of 15 and 49 years referred to Mahdieh and Imam Hossein Hospitals who become LEEP candidates for any reason</inclusion_criteria>
      <agemin>15 years</agemin>
      <agemax>49 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Patients who do not consent to participate in the project
Patients undergoing LEEP for the second time
Patients under 15 years and over 49 years of age.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Surgery</i_code>
      <i_code>Treatment - Surgery</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: All patients referred to the clinic of Mahdieh and Imam Hossein hospitals who are LEEP candidates for any reason are divided into two groups after obtaining consent. In one group, a colposcope is used during the LEEP and the cervix is ​​viewed under armed vision. The LEEP operation is performed and the patients are entered into each group based on a random table. The LEEP operation is performed by two gynecological oncology fellowships. Examined by an experienced pathologist</i_keyword>
      <i_keyword>Control group: Patients referred to the clinic of Mahdieh and Imam Hossein hospitals who are candidates for LEEP for any reason are divided into two groups after obtaining consent. In the control group during LEEP without colposcope and only after applying acetic acid on the cervix and view with the naked eye LEEP operation is performed by two gynecological oncology fellowships. Examined by an experienced pathologist</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Number of parts and sample size of LEEP. Timepoint: After surgery with pathology results. Method of measurement: Number of pieces sent for pathology and length, width and height reported based on pathology answer.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>LEEP sample margin. Timepoint: After surgery with pathology results. Method of measurement: Negative or positive cases reported in pathology.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shahid Beheshti University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-10-26</approval_date>
        <contact_name>Ethics Committee in Biomedical Research of Shahid Beheshti University of Medical Sciences</contact_name>
        <contact_address>Iran TV Street Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
